Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non–lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.

Banach M., Patti A.M., Giglio R.V., Cicero A.F.G., Atanasov A.G., Bajraktari G., et al. (2018). The Role of Nutraceuticals in Statin Intolerant Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(1), 96-118 [10.1016/j.jacc.2018.04.040].

The Role of Nutraceuticals in Statin Intolerant Patients

Patti A. M.;Giglio R. V.;Nikolic D.;Rizzo Manfredi
2018

Abstract

Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non–lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
Banach M., Patti A.M., Giglio R.V., Cicero A.F.G., Atanasov A.G., Bajraktari G., et al. (2018). The Role of Nutraceuticals in Statin Intolerant Patients. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(1), 96-118 [10.1016/j.jacc.2018.04.040].
File in questo prodotto:
File Dimensione Formato  
JACC_banach2018_Nutra and statins int.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 693.42 kB
Formato Adobe PDF
693.42 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/433774
Citazioni
  • ???jsp.display-item.citation.pmc??? 55
  • Scopus 153
  • ???jsp.display-item.citation.isi??? 145
social impact